Novavax includes paediatric subjects in Covid-19 vaccine trial,

Novavax has expanded the ongoing Phase III PREVENT-19 clinical trial of its recombinant protein Covid-19 vaccine candidate, NVX-CoV2373, …, Novavax has expanded the ongoing Phase III PREVENT-19 clinical trial of its recombinant protein Covid-19 vaccine candidate, NVX-CoV2373, …, Read More

Scroll to Top